The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant.


Journal

Genetics in medicine : official journal of the American College of Medical Genetics
ISSN: 1530-0366
Titre abrégé: Genet Med
Pays: United States
ID NLM: 9815831

Informations de publication

Date de publication:
09 2021
Historique:
received: 07 08 2020
accepted: 26 04 2021
pubmed: 12 6 2021
medline: 21 10 2021
entrez: 11 6 2021
Statut: ppublish

Résumé

To evaluate the association between a previously published 313 variant-based breast cancer (BC) polygenic risk score (PRS We included women of European ancestry with a prevalent first primary invasive BC (BRCA1 = 6,591 with 1,402 prevalent CBC cases; BRCA2 = 4,208 with 647 prevalent CBC cases) from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA), a large international retrospective series. Cox regression analysis was performed to assess the association between overall and ER-specific PRS For BRCA1 heterozygotes the estrogen receptor (ER)-negative PRS The PRS

Identifiants

pubmed: 34113011
doi: 10.1038/s41436-021-01198-7
pii: S1098-3600(21)05101-7
pmc: PMC8460445
mid: EMS128250
doi:

Substances chimiques

BRCA1 Protein 0
BRCA1 protein, human 0
BRCA2 Protein 0
BRCA2 protein, human 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1726-1737

Subventions

Organisme : Wellcome Trust
ID : 203477/Z/16/Z
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : R01 CA214545
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : Cancer Research UK
ID : C1287/A16563
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : P30 CA168524
Pays : United States
Organisme : Cancer Research UK
ID : C5047/A10692
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 11174
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C5047/A8384
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : Cancer Research UK
ID : C1287/A 10710
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : U19 CA148065
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20 GM130423
Pays : United States
Organisme : NCI NIH HHS
ID : RC4 CA153828
Pays : United States
Organisme : Cancer Research UK
ID : 10118
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C1281/A12014
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C12292/A2086
Pays : United Kingdom
Organisme : Cancer Research UK
ID : A11174
Pays : United Kingdom
Organisme : NCATS NIH HHS
ID : UL1 TR000124
Pays : United States
Organisme : Cancer Research UK
ID : C12292/A11174
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : U10 CA180822
Pays : United States
Organisme : Cancer Research UK
ID : C5047/A15007
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : UM1 CA164920
Pays : United States
Organisme : NCI NIH HHS
ID : U10 CA180868
Pays : United States
Organisme : Cancer Research UK
ID : C8197/A16565
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : R01 CA192393
Pays : United States
Organisme : Cancer Research UK
ID : C1287/A10118
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : R25 CA112486
Pays : United States

Investigateurs

Emmanuelle Barouk-Simonet (E)
Muriel Belotti (M)
Pascaline Berthet (P)
Yves-Jean Bignon (YJ)
Valérie Bonadona (V)
Brigitte Bressac-de Paillerets (B)
Bruno Buecher (B)
Sandrine Caputo (S)
Olivier Caron (O)
Laurent Castera (L)
Virginie Caux-Moncoutier (V)
Chrystelle Colas (C)
Marie-Agnès Collonge-Rame (MA)
Isabelle Coupier (I)
Antoine de Pauw (A)
Capucine Delnatte (C)
Camille Elan (C)
Laurence Faivre (L)
Sandra Fert Ferrer (SF)
Marion Gauthier-Villars (M)
Paul Gesta (P)
Sophie Giraud (S)
Lisa Golmard (L)
Claude Houdayer (C)
Christine Lasset (C)
Maïté Laurent (M)
Dominique Leroux (D)
Michel Longy (M)
Véronique Mari (V)
Sylvie Mazoyer (S)
Noura Mebirouk (N)
Isabelle Mortemousque (I)
Fabienne Prieur (F)
Pascal Pujol (P)
Claire Saule (C)
Helene Schuster (H)
Nicolas Sevenet (N)
Hagay Sobol (H)
Johanna Sokolowska (J)
Laurence Venat-Bouvet (L)
Munaza Ahmed (M)
Julian Barwell (J)
Angela Brady (A)
Paul Brennan (P)
Carole Brewer (C)
Jackie Cook (J)
Rosemarie Davidson (R)
Alan Donaldson (A)
Alison M Dunning (AM)
Jacqueline Eason (J)
Diana M Eccles (DM)
Helen Gregory (H)
Helen Hanson (H)
Patricia A Harrington (PA)
Alex Henderson (A)
Shirley Hodgson (S)
M John Kennedy (MJ)
Fiona Lalloo (F)
Clare Miller (C)
Patrick J Morrison (PJ)
Kai-Ren Ong (KR)
Aoife O'Shaughnessy-Kirwan (A)
Jo Perkins (J)
Mary E Porteous (ME)
Mark T Rogers (MT)
Lucy E Side (LE)
Katie Snape (K)
Lisa Walker (L)
Gord Glendon (G)
Anna Marie Mulligan (AM)
Christi J van Asperen (CJ)
Cora M Aalfs (CM)
Muriel A Adank (MA)
Margreet G E M Ausems (MGEM)
Marinus J Blok (MJ)
Encarna B Gómez Garcia (EB)
Bernadette A M Heemskerk-Gerritsen (BAM)
Antoinette Hollestelle (A)
Agnes Jager (A)
Linetta B Koppert (LB)
Marco Koudijs (M)
Mieke Kriege (M)
Hanne E J Meijers-Heijboer (HEJ)
Arjen R Mensenkamp (AR)
Thea M Mooij (TM)
Jan C Oosterwijk (JC)
Ans M W van den Ouweland (AMW)
Frederieke H van der Baan (FH)
Annemieke H van der Hout (AH)
Lizet E van der Kolk (LE)
Rob B van der Luijt (RB)
Carolien H M van Deurzen (CHM)
Helena C van Doorn (HC)
Klaartje van Engelen (K)
Liselotte P van Hest (LP)
Theo A M van Os (TAM)
Senno Verhoef (S)
Maartje J Vogel (MJ)
Juul T Wijnen (JT)
Jonathan Beesley (J)
Stephen Fox (S)
Helene Holland (H)
Kelly-Anne Phillips (KA)
Amanda B Spurdle (AB)

Informations de copyright

© 2021. The Author(s).

Références

J Natl Cancer Inst. 2018 Sep 1;110(9):994-1002
pubmed: 29490057
Nat Commun. 2020 Jul 31;11(1):3833
pubmed: 32737321
Nat Genet. 2017 Dec;49(12):1767-1778
pubmed: 29058716
Cancer Epidemiol Biomarkers Prev. 2017 Jan;26(1):126-135
pubmed: 27697780
Breast Cancer Res. 2014 Dec 31;16(6):3416
pubmed: 25919761
Am J Hum Genet. 2019 Jan 3;104(1):21-34
pubmed: 30554720
Cancer Epidemiol Biomarkers Prev. 2018 Apr;27(4):380-394
pubmed: 29382703
Cochrane Database Syst Rev. 2018 Apr 05;4:CD002748
pubmed: 29620792
Int J Methods Psychiatr Res. 2011 Mar;20(1):40-9
pubmed: 21499542
J Clin Oncol. 2016 Feb 10;34(5):409-18
pubmed: 26700119
Breast Cancer Res. 2012 Dec 07;14(6):R156
pubmed: 23216834
Breast Cancer Res. 2007;9(2):104
pubmed: 17466083
Breast. 2019 Apr;44:1-14
pubmed: 30580169
Cancer Res. 2010 Dec 1;70(23):9742-54
pubmed: 21118973
J Natl Cancer Inst. 2017 Oct 1;109(10):
pubmed: 28521362
Breast Cancer Res. 2019 Dec 17;21(1):144
pubmed: 31847907
Am J Hum Genet. 2020 Nov 5;107(5):837-848
pubmed: 33022221
Nat Genet. 2013 Apr;45(4):353-61, 361e1-2
pubmed: 23535729
J Natl Cancer Inst. 2015 Apr 08;107(5):
pubmed: 25855707
Int J Cancer. 2018 Jan 15;142(2):347-356
pubmed: 28921573
J Natl Cancer Inst. 2019 Jul 1;111(7):709-718
pubmed: 30698719
JAMA. 2017 Jun 20;317(23):2402-2416
pubmed: 28632866
Hum Mol Genet. 2009 Nov 15;18(22):4442-56
pubmed: 19656774
Stat Med. 1996 Feb 28;15(4):361-87
pubmed: 8668867
Breast Cancer Res Treat. 2010 Dec;124(3):643-51
pubmed: 20204502
J Natl Cancer Inst. 2013 Jun 5;105(11):812-22
pubmed: 23628597
Br J Cancer. 2011 Apr 26;104(9):1384-92
pubmed: 21487411
J Clin Oncol. 2012 Dec 10;30(35):4330-6
pubmed: 23109704
Am J Surg. 2013 Nov;206(5):704-8
pubmed: 24016706
J Clin Oncol. 2009 Dec 10;27(35):5887-92
pubmed: 19858402
Am J Hum Genet. 2008 Apr;82(4):937-48
pubmed: 18355772
Nature. 2017 Nov 2;551(7678):92-94
pubmed: 29059683
Genet Med. 2020 Oct;22(10):1653-1666
pubmed: 32665703
JAMA. 2011 Feb 23;305(8):822-3
pubmed: 21343582
PLoS Genet. 2013;9(3):e1003212
pubmed: 23544013
J Natl Cancer Inst. 2017 Jul 1;109(7):
pubmed: 28376175
PLoS Genet. 2013;9(3):e1003173
pubmed: 23544012

Auteurs

Inge M M Lakeman (IMM)

Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.

Alexandra J van den Broek (AJ)

Division of Molecular Pathology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.

Juliën A M Vos (JAM)

Division of Molecular Pathology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.

Daniel R Barnes (DR)

Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.

Julian Adlard (J)

Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK.

Irene L Andrulis (IL)

Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, Canada.
Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.

Adalgeir Arason (A)

Department of Pathology, Landspitali University Hospital, Reykjavik, Iceland.
BMC (Biomedical Centre), Faculty of Medicine, University of Iceland, Reykjavik, Iceland.

Norbert Arnold (N)

Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel, Germany.
Institute of Clinical Molecular Biology, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel, Germany.

Banu K Arun (BK)

Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Judith Balmaña (J)

Hereditary cancer Genetics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
Department of Medical Oncology, Vall d'Hebron Barcelona Hospital Campus, University Hospital of Vall d'Hebron, Barcelona, Spain.

Daniel Barrowdale (D)

Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.

Javier Benitez (J)

Centro de Investigación en Red de Enfermedades Raras (CIBERER), Madrid, Spain.
Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.

Ake Borg (A)

Department of Oncology, Lund University and Skåne University Hospital, Lund, Sweden.

Trinidad Caldés (T)

Molecular Oncology Laboratory, CIBERONC, Hospital Clinico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Madrid, Spain.

Maria A Caligo (MA)

SOD Genetica Molecolare. University Hospital, Pisa, Italy.

Wendy K Chung (WK)

Departments of Pediatrics and Medicine, Columbia University, New York, NY, USA.

Kathleen B M Claes (KBM)

Centre for Medical Genetics, Ghent University, Ghent, Belgium.

J Margriet Collée (JM)

Department of Clinical Genetics, Erasmus University Medical Center, CA, Rotterdam, The Netherlands.

Fergus J Couch (FJ)

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.

Mary B Daly (MB)

Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA, USA.

Joe Dennis (J)

Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.

Mallika Dhawan (M)

Cancer Genetics and Prevention Program, University of California San Francisco, San Francisco, CA, USA.

Susan M Domchek (SM)

Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.

Ros Eeles (R)

Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK.

Christoph Engel (C)

Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.

D Gareth Evans (DG)

Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
North West Genomics Laboratory Hub, Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.

Lidia Feliubadaló (L)

Hereditary Cancer Program, ONCOBELL-IDIBELL-IGTP, Catalan Institute of Oncology, CIBERONC, Barcelona, Spain.

Lenka Foretova (L)

Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic.

Eitan Friedman (E)

The Susanne Levy Gertner Oncogenetics Unit, Chaim Sheba Medical Center, Ramat Gan, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel.

Debra Frost (D)

Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.

Patricia A Ganz (PA)

Schools of Medicine and Public Health, Division of Cancer Prevention & Control Research, Jonsson Comprehensive Cancer Centre, UCLA, Los Angeles, CA, USA.

Judy Garber (J)

Cancer Risk and Prevention Clinic, Dana-Farber Cancer Institute, Boston, MA, USA.

Simon A Gayther (SA)

Center for Bioinformatics and Functional Genomics and the Cedars Sinai Genomics Core. Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Anne-Marie Gerdes (AM)

Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

Andrew K Godwin (AK)

Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA.

David E Goldgar (DE)

Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA.

Eric Hahnen (E)

Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Christopher R Hake (CR)

Waukesha Memorial Hospital-Pro Health Care, Waukesha, WI, USA.

Ute Hamann (U)

Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Frans B L Hogervorst (FBL)

Family Cancer Clinic, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.

Maartje J Hooning (MJ)

Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.

John L Hopper (JL)

Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia.

Peter J Hulick (PJ)

Center for Medical Genetics, NorthShore University HealthSystem, Evanston, IL, USA.
The University of Chicago Pritzker School of Medicine, Chicago, IL, USA.

Evgeny N Imyanitov (EN)

N.N. Petrov Institute of Oncology, St. Petersburg, Russia.

Claudine Isaacs (C)

Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.

Louise Izatt (L)

Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London, UK.

Anna Jakubowska (A)

Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, Szczecin, Poland.

Paul A James (PA)

Parkville Familial Cancer Centre, Peter MacCallum Cancer Center, Melbourne, VIC, Australia.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia.

Ramunas Janavicius (R)

Hematology, Oncology and Transfusion Medicine Center, Department of Molecular and Regenerative Medicine, Vilnius University Hospital Santariskiu Clinics, Vilnius, Lithuania.
State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania.

Uffe Birk Jensen (UB)

Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark.

Yue Jiao (Y)

Genetic Epidemiology of Cancer team, Paris, France.
Institut Curie, Paris, France.
Mines ParisTech, Fontainebleau, France.

Esther M John (EM)

Department of Epidemiology & Population Health, Stanford University School of Medicine, Stanford, CA, USA.
Department of Medicine, Division of Oncology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.

Vijai Joseph (V)

Clinical Genetics Research Lab, Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Beth Y Karlan (BY)

David Geffen School of Medicine, Department of Obstetrics and Gynecology, University of California at Los Angeles, Los Angeles, CA, USA.

Carolien M Kets (CM)

Family Cancer Clinic, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.

Irene Konstantopoulou (I)

Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research 'Demokritos', Athens, Greece.

Ava Kwong (A)

Hong Kong Hereditary Breast Cancer Family Registry, Cancer Genetics Centre, Happy Valley, Hong Kong.
Department of Surgery, The University of Hong Kong, Pok Fu Lam, Hong Kong.
Department of Surgery, Hong Kong Sanatorium and Hospital, Happy Valley, Hong Kong.

Clémentine Legrand (C)

Département de Génétique, CHU de Grenoble, Grenoble, France.

Goska Leslie (G)

Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.

Fabienne Lesueur (F)

Genetic Epidemiology of Cancer team, Paris, France.
Institut Curie, Paris, France.
Mines ParisTech, Fontainebleau, France.

Jennifer T Loud (JT)

Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.

Jan Lubiński (J)

Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.

Siranoush Manoukian (S)

Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.

Lesley McGuffog (L)

Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.

Austin Miller (A)

NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY, USA.

Denise Molina Gomes (DM)

Service de Biologie de la reproduction, Cytogénétique et Génétique Médicale, CHI Poissy-Saint Germain, Poissy, France.

Marco Montagna (M)

Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.

Emmanuelle Mouret-Fourme (E)

Service de Génétique, Institut Curie, Paris, France.

Katherine L Nathanson (KL)

Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.

Susan L Neuhausen (SL)

Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, USA.

Heli Nevanlinna (H)

Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.

Joanne Ngeow Yuen Yie (JNY)

Cancer Genetics Service, National Cancer Centre, Singapore, Singapore.
Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.

Edith Olah (E)

Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary.

Olufunmilayo I Olopade (OI)

Center for Clinical Cancer Genetics, The University of Chicago, Chicago, IL, USA.

Sue K Park (SK)

Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.
Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, Korea.
Cancer Research Institute, Seoul National University, Seoul, Korea.

Michael T Parsons (MT)

Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.

Paolo Peterlongo (P)

Genome Diagnostics Program, IFOM-the FIRC Institute of Molecular Oncology, Milan, Italy.

Marion Piedmonte (M)

NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY, USA.

Paolo Radice (P)

Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy.

Johanna Rantala (J)

Clinical Genetics, Karolinska Institutet, Stockholm, Sweden.

Gad Rennert (G)

Clalit National Cancer Control Center, Carmel Medical Center and Technion Faculty of Medicine, Haifa, Israel.

Harvey A Risch (HA)

Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, USA.

Rita K Schmutzler (RK)

Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Priyanka Sharma (P)

Department of Internal Medicine, Division of Medical Oncology, University of Kansas Medical Center, Westwood, KS, USA.

Jacques Simard (J)

Genomics Center, Centre Hospitalier Universitaire de Québec-Université Laval Research Center, Québec City, QC, Canada.

Christian F Singer (CF)

Dept of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.

Zsofia Stadler (Z)

Clinical Genetics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Dominique Stoppa-Lyonnet (D)

Service de Génétique, Institut Curie, Paris, France.
Department of Tumour Biology, INSERM U830, Paris, France.
Université Paris Descartes, Paris, France.

Christian Sutter (C)

Institute of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany.

Yen Yen Tan (YY)

Dept of OB/GYN, Medical University of Vienna, Vienna, Austria.

Manuel R Teixeira (MR)

Department of Genetics, Portuguese Oncology Institute, Porto, Portugal.
Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal.

Soo Hwang Teo (SH)

Breast Cancer Research Programme, Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia.
Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

Alex Teulé (A)

Hereditary Cancer Program, ONCOBELL-IDIBELL-IGTP, Catalan Institute of Oncology, CIBERONC, Barcelona, Spain.

Mads Thomassen (M)

Department of Clinical Genetics, Odense University Hospital, Odence C, Denmark.

Darcy L Thull (DL)

Department of Medicine, Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

Marc Tischkowitz (M)

Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montréal, QC, Canada.
Department of Medical Genetics, National Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge. Vol Box 134, Level 6 Addenbrooke's Treatment Centre, Addenbrooke's Hosptital, Cambridge, UK.

Amanda E Toland (AE)

Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, USA.

Nadine Tung (N)

Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA.

Elizabeth J van Rensburg (EJ)

Department of Genetics, University of Pretoria, Arcadia, South Africa.

Ana Vega (A)

Centro de Investigación en Red de Enfermedades Raras (CIBERER), Madrid, Spain.
Fundación Pública Galega de Medicina Xenómica, Santiago de Compostela, Spain.
Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain.

Barbara Wappenschmidt (B)

Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Peter Devilee (P)

Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.

Christi J van Asperen (CJ)

Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.

Jonine L Bernstein (JL)

Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

Kenneth Offit (K)

Clinical Genetics Research Lab, Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Clinical Genetics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Douglas F Easton (DF)

Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.

Matti A Rookus (MA)

Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands.

Georgia Chenevix-Trench (G)

Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.

Antonis C Antoniou (AC)

Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.

Mark Robson (M)

Clinical Genetics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Marjanka K Schmidt (MK)

Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands. mk.schmidt@nki.nl.
Division of Molecular Pathology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. mk.schmidt@nki.nl.
Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands. mk.schmidt@nki.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH